Keyphrases
Acute Myeloid Leukemia
33%
Bland-Altman Plot
33%
Censored Costs
16%
Clinical Decision-making
6%
Confidence Interval
14%
Control Limits
8%
Denmark
33%
Ecological Analysis
33%
Environmental Exposure
8%
Ever Smokers
13%
Geographical Analysis
33%
Geographical Distribution
12%
Hazard Ratio
6%
Health-related Quality of Life
33%
Hematological Cancer
16%
High-cost Patients
22%
Incidence Rate
8%
Kaplan-Meier Estimator
6%
Leukemia
6%
Life Expectancy
6%
Limits of Agreement
33%
Longitudinal Observational Study
33%
Median Overall Survival
6%
Multiple Measurements
9%
Multiple Myeloma
33%
Multiple Observer
33%
Multivariate Analysis
6%
National Cohort Study
33%
National Incidence
8%
Never Smokers
13%
Overall Survival
13%
Patient-related
6%
Patient-reported Outcomes
33%
Pharmaceutical Expenditure
33%
Potential Identification
33%
Precision Medicine
16%
Prognostic Effect
33%
Prognostic Factors
13%
Prognostic Impact
6%
Progressive Disease
33%
Quality of Life Domains
16%
Relapsed Disease
33%
Rural Areas
8%
Smoke Effect
33%
Smoking Status
33%
Standardized Incidence Ratio
8%
Supportive Care
11%
Targeted Treatment
11%
Urban Areas
8%
Urbanization Impacts
33%
Medicine and Dentistry
Acute Myeloid Leukemia
66%
Cancer Treatment
38%
Clinical Decision Making
8%
Cohort Analysis
38%
Deterioration
16%
Diarrhea
5%
Diffuse Large B-Cell Lymphoma
28%
Hazard Ratio
22%
Health Care Cost
33%
Hematological Cancer
16%
Hematology
5%
Hospital Anxiety and Depression Scale
5%
Identified Patient
5%
Leukemia
8%
Life Expectancy
8%
Malignant Neoplasm
43%
Medical Record
8%
Multiple Myeloma
28%
Multivariate Analysis
8%
Observational Study
33%
Overall Survival
58%
Patient-Reported Outcome
33%
Personalized Medicine
16%
Prognostic Factor
16%
Progressive Disease
33%
Quality of Life
33%
Smoking
33%
Socioeconomic Status
33%
Supportive Care
11%
Survival Estimate
8%
Symptom
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Anticarcinogen
33%
Chemotherapy
41%
Cohort Study
71%
Diffuse Large B Cell Lymphoma
28%
Leukemia
8%
Life Expectancy
8%
Malignant Neoplasm
38%
Multiple Myeloma
61%
Obesity
33%
Overall Survival
69%
Psychotrauma
6%
Recurrence Free Survival
5%
Remission
11%
Survival Time
11%
